Recent publications
Article
Azfr Ali, R, Jalal, Z, Chandan, J, Subramanian, A, Adderley, N, Nirantharakumar, K, Gokhale, K & Paudyal, V 2023, 'Cardiometabolic screening and monitoring in patients prescribed antipsychotic drugs in primary care: A population-based cohort study', Comprehensive Psychiatry, vol. 127, 152419. https://doi.org/10.1016/j.comppsych.2023.152419
Mollan, S, Subramanian, A, Perrins, M, Nirantharakumar, K, Adderley, N & Sinclair, A 2023, 'Depression and anxiety in women with idiopathic intracranial hypertension compared to migraine: a matched controlled cohort study', Headache, vol. 63, pp. 290-298. https://doi.org/10.1111/head.14465
Aiyegbusi, OL, Davies, EH, Myles, PR, Williams, T, Frost, C, Haroon, S, Hughes, S, Wilson, R, McMullan, C, Subramanian, A, Nirantharakumar, K & Calvert, M 2023, 'Digitally enabled decentralised research: opportunities to improve the efficiency of clinical trials and observational studies', BMJ evidence-based medicine. https://doi.org/10.1136/bmjebm-2023-112253
Sheikh, J, Khalil, H, Shaikh, S, Hebbar, M, Zia, N, Wicks, S, Jayaprakash, S, Narendran, A, Subramanian, A, Malhotra, K, Chapman, R, Gillett, C, Gleeson, H, Robinson, L, Justin, C, Lathia, T, Selvan, C, O'reilly, M, Manolopoulos, K, Arlt, W, Kempegowda, P & PCOS SEva team 2023, 'Emotional and psychosexual wellbeing is influenced by ethnicity and birthplace in women and individuals with polycystic ovary syndrome in the UK and India', BJOG: An International Journal of Obstetrics & Gynaecology, vol. 130, no. 8, pp. 978-986. https://doi.org/10.1111/1471-0528.17428
Karasik, A, Lanzinger, S, Tan, EC, Yabe, D, Kim, DJ, Sheu, WH, Melzer-Cohen, C, Holl, RW, Ha, KH, Khunti, K, Zaccardi, F, Subramanian, A, Nirantharakumar, K, Nyström, T, Niskanen, L, Jensen, ML, Hoti, F, Klement, R, Déruaz-Luyet, A, Kyaw, MH, Koeneman, L, Vistisen, D, Carstensen, B, Halvorsen, S, Langslet, G, Farsani, SF, Patorno, E & Núñez, J 2023, 'Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study.', Diabetes & Metabolism, vol. 49, no. 2, 101418. https://doi.org/10.1016/j.diabet.2022.101418
Vistisen, D, Carstensen, B, Elisabetta, P, Lanzinger, S, Tan, EC-H, Yabe, D, Kim, DJ, Sheu, WH-H, Melzer-Cohen, C, Holl, RW, Núñez, J, Ha, KH, Halvorsen, S, Langslet, G, Karasik, A, Nyström, T, Niskanen, L, Guleria, S, Klement, R, Carrasco, M, Foersch, J, Shay, C, Koeneman, L, Hoti, F, Farsani, SF, Khunti, K, Zaccardi, F, Subramanian, A & Nirantharakumar, K 2023, 'Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia', Cardiovascular diabetology, vol. 22, no. 1, 233. https://doi.org/10.1186/s12933-023-01963-9
Syed, U, Subramanian, A, Wraith, D, Lord, J, McGee, K, Gokhale, K, Nirantharakumar, K & Haroon, S 2023, 'Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care', BMC Medicine, vol. 21, no. 1, 363. https://doi.org/10.1186/s12916-023-03049-5
Shah, AD, Subramanian, A, Lewis , J, Dhalla , S, Ford , E, Haroon, S, Kuan , V & Nirantharakumar, K 2023, 'Long Covid symptoms and diagnosis in primary care: a cohort study using structured and unstructured data in The Health Improvement Network primary care database', PLOS One. <http://www.plosone.org/>
Lee, S, Hope, HF, O'Reilly, D, Kent, L, SANTORELLI, G, Subramanian, A, Moss, N, Azcoaga-Lorenzo, A, FAGBAMIGBE, AF, Nelson-Piercy, C, Yau, C, McCowan, C, Kennedy, JI, Phillips, K, Singh, M, Mhereeg, M, Cockburn, N, Brocklehurst, P, Plachcinski, R, Riley, R, Thangaratinam, S, Brophy, S, Sudasinghe, B, Agrawal, U, VOWLES, Z, Abel, KM, Nirantharakumar, K, Black, M & Eastwood, KA 2023, 'Maternal and child outcomes for pregnant women with pre-existing multiple long-term conditions: protocol for an observational study in the United Kingdom', BMJ open, vol. 13, e068718. https://doi.org/0.1136/bmjopen-2022-068718
MuM-PreDiCT Group 2023, 'Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019', BMC medicine, vol. 21, no. 1, 21. https://doi.org/10.1186/s12916-022-02722-5
MuM-PreDiCT Group 2023, 'Prevalence of polypharmacy in pregnancy: a systematic review', BMJ open, vol. 13, no. 3, e067585. https://doi.org/10.1136/bmjopen-2022-067585
Lee, SI, Hanley, S, Vowles, Z, Plachcinski, R, Moss, N, Singh, M, Gale, C, Fagbamigbe, AF, Azcoaga-Lorenzo, A, Subramanian, A, Taylor, B, Nelson-Piercy, C, Damase-Michel, C, Yau, C, McCowan, C, O’Reilly, D, Santorelli, G, Dolk, H, Hope, H, Phillips, K, Abel, KM, Eastwood, K-A, Kent, L, Locock, L, Loane, M, Mhereeg, M, Brocklehurst, P, McCann, S, Brophy, S, Wambua, S, Hemali Sudasinghe, SPB, Thangaratinam, S, Nirantharakumar, K & Black, M 2023, 'The development of a core outcome set for studies of pregnant women with multimorbidity', BMC medicine, vol. 21, no. 1, 314. https://doi.org/10.1186/s12916-023-03013-3
Russell, R, Minhas, S, Chandan, JS, Subramanian, A, McCarthy, N & Nirantharakumar, K 2023, 'The risk of all-cause mortality associated with Anxiety: A retrospective cohort study using ‘The Health Improvement Network’ database', BMC Psychiatry, vol. 23, no. 1, 400. https://doi.org/10.1186/s12888-023-04877-8
Comment/debate
Thaller, M, Adderley, N, Subramanian, A, Mollan, S & Sinclair, A 2023, 'Comorbid polycystic ovarian syndrome in idiopathic intracranial hypertension', Neuro-Ophthalmology, vol. 47, no. 1, pp. 49-52. https://doi.org/10.1080/01658107.2022.2162089
Review article
TLC Study Group 2023, 'Considerations for patient and public involvement and engagement in health research', Nature Medicine.
View all publications in research portal